Treatment rate and factors related to interferon-based treatment initiation for chronic hepatitis C in South Korea.

doi:10.1002/jmv.24335

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

Treatment rate and factors related to interferon-based treatment initiation for chronic hepatitis C in South Korea.

Journal of medical virology - 1 Feb 2016

Lee Sang Soo, Jeong Sook-Hyang, Jang Eun Sun, Kim Young Seok, Lee Youn Jae, Jung Eun Uk, Kim In Hee, Bae Si Hyun, Lee Han Chu

Abstract excerpt

Under-recognition and under-treatment of chronic hepatitis C virus (HCV) infection is an important determinant of the disease outcome. The aim of this study was to investigate the treatment rate and factor of initiation of interferon-based antiviral treatment for chronic hepatitis C patients in a prospective, multicenter Korean HCV cohort. Treatment-naïve 759 patients with chronic HCV infection were prospectively...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carcinoma, Hepatocellular
Share to Hepatitis C, Chronic

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hospitals, University

Share to Interferon-alpha

Share to Liver Cirrhosis

Share to Liver Function Tests

Share to Republic of Korea

Share to Ribavirin

Source

Open in PubMed

Identifiers

PMID: 26211752
DOI: 10.1002/jmv.24335

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.